copd

Latest stories

  • in Health care

    Glenmark Gets CDSCO panel nod for Phase IV CT of COPD drug

    by

    New Delhi: Pharmaceutical major, Glenmark has got the green signal from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) to conduct the Phase IV clinical trial of the fixed dose combination (FDC) Glycopyrrolate plus Budesonide plus Formoterol Fumarate dihydrate actuation delivers inhalation aerosol. However, this approval is subjected to […] More

  • in Health care

    Sun Pharma gets CDSCO panel nod to study COPD drug combination

    by

    New Delhi: Pharmaceutical major, Sun Pharma has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) to conduct the active Post-marketing Surveillance (PMS) Study of the fixed-dose combination drug Fluticasone Furoate 200mcg plus Vilanterol 25mcg powder for inhalation. However, this approval is subject to conditions that […] More